π
|
Blockade of XBP1 splicing by inhibition of IRE1Ξ± is a promising therapeutic option in multiple myeloma.
25 auth.
N. Mimura,
M. Fulciniti,
G. Gorgun,
Y. Tai,
D. Cirstea,
L. Santo,
Yiguo Hu,
C. Fabre,
J. Minami,
H. Ohguchi,
T. Kiziltepe,
H. Ikeda,
Y. Kawano,
Maureen French,
M. Blumenthal,
...
Victor L Tam,
N. Kertesz,
U. Malyankar,
M. Hokenson,
T. Pham,
Qingping Zeng,
J. Patterson,
P. Richardson,
N. Munshi,
K. Anderson
|
8 |
2011 |
8 π
|
π
|
Nucling, a Novel Apoptosis-associated Protein, Controls Mammary Gland Involution by Regulating NF-ΞΊB and STAT3*
7 auth.
H. Dang,
T. Sakai,
T. Pham,
D. H. Tran,
K. Yorita,
Y. Shishido,
...
K. Fukui
|
3 |
2015 |
3 π
|
π¦
|
Intracellular PRPP concentration and metabolism as a determinant of 5-fluorouracil response in murine colonic adenocarcinomas
T. Pham,
B. Ardalan,
D. Villacorte
|
1 |
1981 |
1 π¦
|
π¬
|
Human recombinant platelet activating factor acetylhydrolase (rPAF-AH) alters the inflammatory response in the HLA-B27+transgenic rat model
M. B. Bowen-Yacyshyn,
Norma Yachimec,
T. Pham,
G. Dietsch,
B. Yacyshyn
|
0 |
2000 |
0 π¬
|
π
|
Sofosbuvir-Based Direct Acting Antiviral Therapy of Recurrent HCV Infection Following Liver Transplant
7 auth.
Courtney Walker,
J. Hatch,
N. McBride,
T. Pham,
Ray Thomason,
T. Box,
...
J. Gallegos-Orozco
|
0 |
2018 |
0 π
|
π’
|
S2543βPolycystic Liver Disease, Portal Hypertension, and Refractory Ascites: Is PLD the Cause?
Jason Dubroff,
J. Bank,
T. Pham
|
0 |
2020 |
0 π’
|
π¬
|
Study of the chemoattractant capacity and opsonizing capacity of the ascites fluid in 47 patients with cirrhosis or peritoneal carcinomatosis
F. Mal,
T. Pham,
M. Bendahou,
J. Trinchet,
M. Garnier,
M. Beaugrand
|
0 |
1989 |
0 π¬
|
π¦
|
The effect of TCDD on cytokine production during the progression of insulitis in NOD mice
T. Pham
|
0 |
2013 |
0 π¦
|